Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
Novoyatleva et al investigate the role of receptor tyrosine kinase Axl in Pulmonary arterial hypertension (PAH), finding that the small molecule inhibitor R428 reduces human pulmonary arterial smooth muscle cells proliferation and migration, but causes toxicity in human pulmonary arterial endothelia...
Guardado en:
Autores principales: | Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, Swathi Veeroju, Isabel Ben-Batalla, Paola Caruso, Mazen Shihan, Nadine Presser, Elsa Götz, Carina Lepper, Sebastian Herpel, Grégoire Manaud, Frédéric Perros, Henning Gall, Hossein Ardeschir Ghofrani, Norbert Weissmann, Friedrich Grimminger, John Wharton, Martin Wilkins, Paul D. Upton, Sonja Loges, Nicholas W. Morrell, Werner Seeger, Ralph T. Schermuly |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9cdae1283c834b96804aa01aec8d92af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
por: Astrid Weiss, et al.
Publicado: (2019) -
Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling.
por: Xia Tian, et al.
Publicado: (2011) -
Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension
por: Mazen Shihan, et al.
Publicado: (2021) -
Targeting AXL in NSCLC
por: Zaman A, et al.
Publicado: (2021) -
Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension
por: Guillermo Pousada, et al.
Publicado: (2017)